What a therapeutic peptide can and cannot do
A peptide is a size class, not a promise. What it can do with specificity, what it cannot cross, and why two peptides can have opposite effects.

A therapeutic peptide can do something a small molecule often cannot: block the interaction between two proteins with high specificity. And there are two things it cannot do on its own: cross the cell membrane, and survive for long inside the body. Most claims about peptides fail by ignoring one of those two halves.
What it can do
Its advantage comes from its shape. Peptides activate cell-surface receptors with high affinity and high specificity, in a mode of action similar to biologics.
Against antibodies and therapeutic proteins they hold two concrete advantages: they trigger less immune response, and they cost less to produce.
Against small molecules, the difference is size, and here size works in their favour. A protein-to-protein interaction occupies a contact area of 1500 to 3000 Ų, while a small molecule only manages to cover 300 to 1000 Ų. That is why inhibiting such an interaction is so hard for a small molecule, and something a peptide can do. In practice, that characteristic is why peptide treatment requires prior medical assessment: see the peptide therapy protocol.
What it cannot do
The two limitations are intrinsic: they come with the molecule and are not fixed by increasing the amount.
It does not cross the cell membrane. Permeability depends on length and amino acid composition, but in general peptides cannot enter the cell, so they only reach extracellular targets. In 2018, Lau and Dunn reported that more than 90% of peptides in active clinical development targeted extracellular targets, among them G protein-coupled receptors, the GnRH receptor, and the GLP-1 receptor.
It does not survive unprotected. The chain is held by amide bonds and lacks the structure that defends it inside a protein. Those bonds hydrolyse easily, and the result is a short half-life and rapid elimination.
Why the target shapes everything else
That 90% is not a statistical curiosity. It means nearly all therapeutic peptides act on receptors sitting on the cell surface, rather than on internal mechanisms.
That explains where peptides show up in medicine. Hormonal signals are received at the surface, so treatments that mimic or block hormones tend to be peptides: insulin, GLP-1 analogues, or GnRH analogues. The GLP-1 case is the best known.
How the limitations are offset
Both shortcomings are addressed by modifying the molecule, as explained in what a therapeutic peptide is. The sequence is altered to preserve potency while gaining stability, and chains can also be attached to slow elimination. That is the work behind why some are given once a week rather than daily.
Neither technique turns a peptide into something else. They still act on surface receptors and still require a prescription.
One point worth understanding well
"Peptide" describes a size class, not an effect. Two peptides can do the opposite of each other.
The clearest example is gonadotropin-releasing hormone, a ten-amino-acid peptide. Modifying its sequence produced drugs with opposite effects from the same base: leuprolide acts as an agonist, activating the receptor, while degarelix acts as an antagonist, competing for it.
In other words: knowing something is a peptide tells you nothing about what it does, or whether it suits a particular case. That judgement depends on the individual's profile and on review by a licensed professional.
What this means when you read about peptides
If a text presents "peptides" as a category with one shared effect, it is using the word as a selling point rather than a description. A class of molecules defined by size cannot have a single effect.
The useful question is not whether peptides work. It is which peptide, on which receptor, with which modification, and in whom.
On compounded formulations: the base active ingredient holds FDA approval in its brand-name reference medicines. Personalised compounded formulations are prepared and dispensed by state-licensed 503A pharmacies under strict individualised medical prescription following a clinical consultation. A compounded medicine is not an FDA-approved equivalent of a brand-name product.
Frequently asked questions
Do peptides work?
It depends on the molecule, the receptor it acts on, and the person. "Do peptides work?" has no single answer, because peptides are not a single thing.
Why do most of them act on surface receptors?
Because they do not cross the cell membrane well. More than 90% of those in clinical development target extracellular sites.
Is a natural peptide safer than a modified one?
Not necessarily. The modifications exist to correct the lack of stability and rapid degradation, which are the two built-in problems. A natural peptide may be cleared before producing the intended effect.
What if a peptide has the opposite effect to what I expected?
It is possible, and the GnRH case proves it: the same base molecule yields an agonist and an antagonist depending on how it is modified. That is why the effect cannot be inferred from the family name.
Can I start peptide treatment on my own?
No. These are prescription medicines with documented adverse effects. Individual results vary according to each person's biological response, and the indication is a licensed professional's call.
If you want to know whether peptide treatment is right for you
A licensed professional reviews your history, your medication, and your background before any treatment is considered, and follow-up continues after the initial consultation.
Start your clinical evaluation →
Sources
- Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, Wang X, Wang R, Fu C. Therapeutic peptides: current applications and future directions. *Signal Transduction and Targeted Therapy.* 2022;7(1):48. doi:10.1038/s41392-022-00904-4. Licence CC BY 4.0.
- Lau JL, Dunn MK. Therapeutic peptides: historical perspectives, current development trends, and future directions. *Bioorganic & Medicinal Chemistry.* 2018;26(10):2700-2707. doi:10.1016/j.bmc.2017.06.052.
- FDA. Compounding Laws and Policies. `https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies`
Medical Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Always consult your physician before making any changes to your medication or lifestyle regimen.
Interested in personalized medical protocols?
Explore our compounded GLP-1, 503A Peptides, and hormone optimization options.